SP1-independent inhibition of FOXM1 by modified thiazolidinediones
Seyed Amirhossein Tabatabaei Dakhili, David Pérez, Keshav Gopal, Moinul Haque, John R. Ussher, Khosrow Kashfi, Carlos A. Velázquez‐Martínez
Topics & Concepts
ChemistryThiazolidinedioneTroglitazoneReporter geneFOXM1Electrophoretic mobility shift assayIn vitroLigand binding assayPioglitazoneTranscription factorBiochemistryPharmacologyGene expressionPeroxisome proliferator-activated receptorReceptorGeneBiologyDiabetes mellitusType 2 diabetesEndocrinologyFOXO transcription factor regulationMetabolism, Diabetes, and CancerSignaling Pathways in Disease